Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)

Matthew J. Wieduwilt; Wendy Stock; Anjali Advani; Selina Luger; Richard A. Larson; Martin Tallman; Frederick Appelbaum; Mei Jie Zhang; Khalid Bo-Subait; Hai Lin Wang; Vijaya Raj Bhatt; Bhagirathbhai Dholaria; Mary Eapen; Mehdi Hamadani; Omer Jamy; Tim Prestidge; Michael Pulsipher; David Ritchie; David Rizzieri; Akshay Sharma; Pere Barba; Brenda M. Sandmaier; Marcos de Lima; Partow Kebriaei; Mark Litzow; Wael Saber; Daniel Weisdorf

doi:10.1038/s41375-021-01303-4

Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)

Matthew J. Wieduwilt, Wendy Stock, Anjali Advani, Selina Luger, Richard A. Larson, Martin Tallman, Frederick Appelbaum, Mei Jie Zhang, Khalid Bo-Subait, Hai Lin Wang, Vijaya Raj Bhatt, Bhagirathbhai Dholaria, Mary Eapen, Mehdi Hamadani, Omer Jamy, Tim Prestidge, Michael Pulsipher, David Ritchie, David Rizzieri, Akshay SharmaPere Barba, Brenda M. Sandmaier, Marcos de Lima, Partow Kebriaei, Mark Litzow, Wael Saber, Daniel Weisdorf

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

The article requires a correction in the funding/acknowledgement statement used. There is a grant number (OT3HL147741) in the “Acknowledgments” section that needs to be removed. The original publication was updated.

Original language	English (US)
Pages (from-to)	2140
Number of pages	1
Journal	Leukemia
Volume	35
Issue number	7
DOIs	https://doi.org/10.1038/s41375-021-01303-4
State	Published - Jul 2021

Bibliographical note

Publisher Copyright:
Copyright © The Author(s), under exclusive licence to Springer Nature Limited 2021.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/s41375-021-01303-4

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)'. Together they form a unique fingerprint.

Cite this

Wieduwilt, M. J., Stock, W., Advani, A., Luger, S., Larson, R. A., Tallman, M., Appelbaum, F., Zhang, M. J., Bo-Subait, K., Wang, H. L., Bhatt, V. R., Dholaria, B., Eapen, M., Hamadani, M., Jamy, O., Prestidge, T., Pulsipher, M., Ritchie, D., Rizzieri, D., ... Weisdorf, D. (2021). Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5). Leukemia, 35(7), 2140. https://doi.org/10.1038/s41375-021-01303-4

Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5). / Wieduwilt, Matthew J.; Stock, Wendy; Advani, Anjali et al.
In: Leukemia, Vol. 35, No. 7, 07.2021, p. 2140.

Research output: Contribution to journal › Comment/debate › peer-review

Wieduwilt, MJ, Stock, W, Advani, A, Luger, S, Larson, RA, Tallman, M, Appelbaum, F, Zhang, MJ, Bo-Subait, K, Wang, HL, Bhatt, VR, Dholaria, B, Eapen, M, Hamadani, M, Jamy, O, Prestidge, T, Pulsipher, M, Ritchie, D, Rizzieri, D, Sharma, A, Barba, P, Sandmaier, BM, de Lima, M, Kebriaei, P, Litzow, M, Saber, W & Weisdorf, D 2021, 'Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)', Leukemia, vol. 35, no. 7, pp. 2140. https://doi.org/10.1038/s41375-021-01303-4

Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M et al. Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5). Leukemia. 2021 Jul;35(7):2140. doi: 10.1038/s41375-021-01303-4

Wieduwilt, Matthew J. ; Stock, Wendy ; Advani, Anjali et al. / Correction : Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5). In: Leukemia. 2021 ; Vol. 35, No. 7. pp. 2140.

@article{fee5c3cbeb8047309c401d5bc5ba53fc,

title = "Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)",

abstract = "The article requires a correction in the funding/acknowledgement statement used. There is a grant number (OT3HL147741) in the “Acknowledgments” section that needs to be removed. The original publication was updated.",

author = "Wieduwilt, {Matthew J.} and Wendy Stock and Anjali Advani and Selina Luger and Larson, {Richard A.} and Martin Tallman and Frederick Appelbaum and Zhang, {Mei Jie} and Khalid Bo-Subait and Wang, {Hai Lin} and Bhatt, {Vijaya Raj} and Bhagirathbhai Dholaria and Mary Eapen and Mehdi Hamadani and Omer Jamy and Tim Prestidge and Michael Pulsipher and David Ritchie and David Rizzieri and Akshay Sharma and Pere Barba and Sandmaier, {Brenda M.} and {de Lima}, Marcos and Partow Kebriaei and Mark Litzow and Wael Saber and Daniel Weisdorf",

note = "Publisher Copyright: Copyright {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2021.",

year = "2021",

month = jul,

doi = "10.1038/s41375-021-01303-4",

language = "English (US)",

volume = "35",

pages = "2140",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Correction

T2 - Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR (Leukemia, (2021), 35, 7, (2076-2085), 10.1038/s41375-021-01213-5)

AU - Wieduwilt, Matthew J.

AU - Stock, Wendy

AU - Advani, Anjali

AU - Luger, Selina

AU - Larson, Richard A.

AU - Tallman, Martin

AU - Appelbaum, Frederick

AU - Zhang, Mei Jie

AU - Bo-Subait, Khalid

AU - Wang, Hai Lin

AU - Bhatt, Vijaya Raj

AU - Dholaria, Bhagirathbhai

AU - Eapen, Mary

AU - Hamadani, Mehdi

AU - Jamy, Omer

AU - Prestidge, Tim

AU - Pulsipher, Michael

AU - Ritchie, David

AU - Rizzieri, David

AU - Sharma, Akshay

AU - Barba, Pere

AU - Sandmaier, Brenda M.

AU - de Lima, Marcos

AU - Kebriaei, Partow

AU - Litzow, Mark

AU - Saber, Wael

AU - Weisdorf, Daniel

PY - 2021/7

Y1 - 2021/7

N2 - The article requires a correction in the funding/acknowledgement statement used. There is a grant number (OT3HL147741) in the “Acknowledgments” section that needs to be removed. The original publication was updated.

AB - The article requires a correction in the funding/acknowledgement statement used. There is a grant number (OT3HL147741) in the “Acknowledgments” section that needs to be removed. The original publication was updated.

UR - http://www.scopus.com/inward/record.url?scp=85107597501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107597501&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01303-4

DO - 10.1038/s41375-021-01303-4

M3 - Comment/debate

C2 - 34088982

AN - SCOPUS:85107597501

SN - 0887-6924

VL - 35

SP - 2140

JO - Leukemia

JF - Leukemia

IS - 7

ER -